| Determinants and functions of CAFs secretome during cancer progression and therapy J Linares, JA Marín-Jiménez, J Badia-Ramentol, A Calon Frontiers in Cell and Developmental Biology 8, 2020 | 63 | 2020 |
| Testing cancer immunotherapy in a human immune system mouse model: correlating treatment responses to human chimerism, therapeutic variables and immune cell phenotypes JA Marín-Jiménez, A Capasso, MS Lewis, SM Bagby, SJ Hartman, ... Frontiers in Immunology 12, 607282, 2021 | 25 | 2021 |
| Facts and hopes in immunotherapy of endometrial cancer JA Marín-Jiménez, S García-Mulero, X Matías-Guiu, JM Piulats Clinical Cancer Research 28 (22), 4849-4860, 2022 | 21 | 2022 |
| Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models J Lang, AD Leal, JA Marín-Jiménez, SJ Hartman, J Shulman, NM Navarro, ... Frontiers in Oncology 12, 877635, 2022 | 6 | 2022 |
| Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread N Gendrau‐Sanclemente, A Figueras, K Gracova, Á Lahiguera, ... Molecular Oncology 18 (1), 136-155, 2024 | 1 | 2024 |
| Paclitaxel plus Cetuximab as induction chemotherapy for patients with Locoregionally advanced head and neck squamous cell carcinoma unfit for cisplatin-based chemotherapy JA Marín-Jiménez, M Oliva, P Peinado Martín, S Cabezas-Camarero, ... Frontiers in Oncology 12, 953020, 2022 | 1 | 2022 |
| Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint inhibition by immune modulation in humanized mouse models. J Lang, AD Leal, SJ Hartmann, J Marin-Jimenez, J Shulman, A Capasso, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 84-85, 2020 | 1 | 2020 |
| Abstract A109: Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint inhibition by immune modulation in humanized mouse models J Lang, AD Leal, SJ Hartmann, J Marin-Jimenez, J Shulman, A Capasso, ... Cancer Immunology Research 8 (3_Supplement), A109-A109, 2020 | 1 | 2020 |
| S1PR1 directs tumorsphere proliferation in ovarian cancer N Gendrau-Sanclemente, A Figueras, K Gracova, E Alsina-Sanchís, ... Cancer Research 84 (6_Supplement), 1553-1553, 2024 | | 2024 |
| A phase II trial of avelumab in combination with pegylated liposomal doxorubicin in recurrent/metastatic endometrial cancer (GEICO 70-E): analysis according to molecular … JM Piulats Rodriguez, I Palacio Vazquez, JD Alarcon, S Gatius, ... ANNALS OF ONCOLOGY 34, S519-S519, 2023 | | 2023 |
| # 983 KELIM during neoadjuvant chemotherapy as predictor of interval debulking surgery and treatment response in advanced ovarian cancer ZV Sepulveda, JA Marín-Jimenez, I Ortiz, S Fernández, C Ortega, ... International Journal of Gynecologic Cancer 33 (Suppl 3), 2023 | | 2023 |
| Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors JM Lanis, MS Lewis, H Strassburger, K Larsen, SM Bagby, ... JoVE (Journal of Visualized Experiments), e64606, 2022 | | 2022 |
| Determinants and functions of CAFs secretome during cancer progression and therapy JL Linares Aceituno, JA Marín Jiménez, J Badia-Ramentol, A Calon Front Cell Dev Biol. 2021; 8: 621070, 2021 | | 2021 |
